Manus Aktteva Biopharma
Manus Aktteva Biopharma, a prominent player in the biopharmaceutical industry, is headquartered in India and operates extensively across various global markets. Founded in 2010, the company has established itself as a leader in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and advanced drug delivery systems. With a strong focus on innovation, Manus Aktteva Biopharma offers a diverse portfolio of products, including complex generics and specialty pharmaceuticals, which are distinguished by their superior quality and efficacy. The company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market position. Recognised for its commitment to excellence, Manus Aktteva continues to drive advancements in biopharma, contributing to improved healthcare solutions worldwide.
DitchCarbon Score
How does Manus Aktteva Biopharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Manus Aktteva Biopharma's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Manus Aktteva Biopharma's reported carbon emissions
Manus Aktteva Biopharma, headquartered in India, currently does not have available data on carbon emissions, including specific figures for Scope 1, 2, or 3 emissions. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting practices. As the biopharma industry increasingly prioritises sustainability, Manus Aktteva Biopharma may need to establish clear emissions reduction strategies and targets to align with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Manus Aktteva Biopharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
